Home › Funds › FORA Capital, LLC › BSX

FORA Capital, LLC position in BSX

BOSTON SCIENTIFIC CORP · Health Care

FORA Capital, LLC reported holding 748,271 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$32.7M, representing 1.29% of its reported portfolio and ranking #14 among its reported holdings. FORA Capital, LLC has disclosed BSX holdings in 6 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)748.27K sh
Reported value held$32.67M
Portfolio Weight1.29%
First reportedQ1 2025
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How FORA Capital, LLC's BSX position evolved

FORA Capital, LLC first disclosed a stake in BSX in Q1 2025 at 50,983 shares (US$5.1M). The position peaked in Q3 2026 at 748,271 shares, worth US$32.7M. Across 6 filings, FORA Capital, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 748,271 shares valued at US$32.7M — a reduction of -7,998 shares quarter over quarter.. Notable position changes include a 94% trim in Q2 2025 (shares fell 9% over the following quarter), a 3044% increase in Q1 2026 (shares fell 32% over the following quarter), a 104% increase in Q2 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 50.98K $5.14M New
Q2 2025 3.13K $336.52K Reduce
Q4 2025 11.80K $919.27K New
Q1 2026 370.93K $23.27M Add
Q2 2026 756.27K $32.28M Add
Q3 2026 748.27K $32.67M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), Arrowstreet Capital (US$1.24B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has FORA Capital, LLC held BSX?

FORA Capital, LLC has disclosed BSX holdings in 6 of the last 7 reported quarters, going back to Q1 2025.

What is FORA Capital, LLC's current position in BSX?

As of Q3 2026, FORA Capital, LLC holds 748.27K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $32.67M, representing 1.29% of its reported portfolio and ranking #14.

Has FORA Capital, LLC been buying or selling BSX?

In the latest 13F filing (Q3 2026), FORA Capital, LLC reduced its position in BSX. The position peaked in Q3 2026 at 748.27K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, Arrowstreet Capital, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.